Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Finzelberg GmbH & Co. KG

Clinicaltrial registered16 Nov 2026

Finzelberg GmbH & Co. KG

16 Nov 2026: Trial registered · Effects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy Adults. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
16 Nov 2026
Title
Effects of a Botanical Extract on Cognitive Performance and Cerebral Blood Flow in Healthy Adults
Conditions
Cognitive Change, Cerebral Blood Flow, Memory, Stress (Psychology)
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Germany, Ireland
Country
Germany
Reference
NCT07939334
Location
Germany, Ireland
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Finzelberg GmbH & Co. KG

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Germany

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.